TCVL Vit C
TCVL Vit C
1. Description 46
1.1 Nomenclature 46
1.2 Formulae 46
1.3 Molecular Weight 47
I .4 Elemental Composition 47
1.5 Appearance, Color, Odor, and Taste 47
2. Physical Properties 47
2.1 Crystal Properties 47
2.2 Solubility 48
2.3 Specific Rotation 48
2.4 Dissociation Constant 49
2.5 Identification 49
2.6 Spectral Properties 51
3. Preparation 61
3.1 Isolation 61
3.2 Synthesis 63
4. Biosynthesis of Ascorbic Acid 63
5. Metabolism 66
6. Daily Requirement 66
7. Mode of Action 66
8. Vitamin Deficiency 67
9. Methods of Analysis 67
9.1 Titrimetric Methods 67
9.2 Spectrophotometric Methods 70
9.3 Turbidimetric Method 73
9.4 Chromatographic Methods 73
9.5 Enzymatic Method 75
9.6 Polarographic Method 15
9.7 Chronometric Method 75
10. References 76
1, Description
1.1. Nomenclature
a) L-Ascorbic a c i d
b) L-Xyloascorbic a c i d
c) 3-0x0-L-gluofuranolactone (enol form).
d) L-3-Ketothreohexuronic a c i d l a c t o n e
Vitamin C ; A s c o r b i c a c i d
Adenex; A l l e r c o r b ; A n t i s c o r b u t i c Vitamin;
Ascorbicap; Ascorbajen; A s c o r i l ; A sc o ri n ;
A s c o r t e a l ; A s c o r v i t ; Cantan; C a n t a x i n ; Cata-
v i n C ; Ce b i c u r e ; Cebid; Cebione; Cecon;
Cegiol an ; Cell i n ; Cenetone; Cereon; Cergona;
Ce s c o r b a t ; Cetamid; Cetan; Cetemican; Ceva-
l i n ; Ce v a t i n e ; Cevex; Cevimin; Cevi-Bid;
Ce-Vi-Sol; Cevitamin; C e v i t a n ; Cimin; C e v i t a -
mic Acid; C e v i t e x ; Ciamin; C i p c a ; C o l a s c o r ;
Concemin; C-vimin; Davitamon C ; E r i v i t C ;
Hybrin; L a r o s c o r b i n e ; Lemascorb; Megascorb;
P l a n a v i t C ; Pr o s c o r b i n C ; Redoxon; Ribena;
Sc o r b a c i d ; Scorbu-C; T e s t a s c o r b i c ; V i c e l a t ;
V i t a c e ; V i t a c i mi n ; V i t a c i n ; V i t a s c o r b o l ;
Vitix.
1.2 Formulae
1.2.1 Empirical
‘gH8’6
HR=o
1.2.2 Structural CtI*OtI
I
HOCH
HO OH
ASCORBIC ACID 41
(50-81-7)
176.12
2.2 So lubi1ity
l9 + 24 (water) (2).
['I 5780
l8 + 116 (sodium salt in neutral solution) ( 4 )
5780
l8
+ 130 (N/20 NaoH) ( 2 ) .
5780
(2).
5780 + 149 (N/l NaoH)
l8
I'[ l8
5780
+ 155 (N/2 NaoH) (2)
XI Dissolve 15 mg in 15 ml of a solution of
trichloroacetic acid (1 in 201, add about
200 mg of activated charcoal, shake the
mixture vigorously for 1 minute, and filter
through a small fluted filter, returning the
filtrate, if necessary, until clear. To 5 ml
of the filtrate add 1 drop of pyrrole, and
agitate gently until dissolved, then heat
in a bath at 50": a blue color develops ( 7 ) .
'max (nm)
'max (nm>
. . .
200 210 225 230 2 4 250 260 270 284 2YO 300 310 2 0 3% 3u) 350 3m 380 390
'
4.10(m) 4.68(m) 4.33 (m) 6-H
3.77(s) 4.40(s) 4.36 (s)
3.68(d) 4.30(s) 4.23 (d) 7-CH2
11
I
HO - c 6-
I
177 1.0 M + l
176 5.9 M +
1
116 100.0
85 36.0
71
70
24.7
23.1
HF
H
H o g
61 29.7
a'
HO-
'i'
C
PH
- 0
C
I I
H H
3. Preparation
3.1 Isolation
CH20H
CH20H CH20H
I I I
HO - C -
I
H IIO - C - H co
HO - C - H I I
HO- C- H HO- C--B
I H? I Acetobactv I
H -C-O€i B- C- OH H- C- OH
I cat. I I
HO -c - B HO - C - I-;
suboxydans
HO - c - H
I I I
CHO
Ct120H CH20€i
D-glucose
G-sorbitol L-sorbose
COOH
I
co
I
HO - c-
I
acetone + (1)*<Mn04 ~
ki - C - OH
I
H+ ( 2 ) H 2 0 (H+) I
H - -E
9:CMe2 HO C
I
CH OII
2,3,4,6-diacetone sorbose 2
2-keto-L-gulonic acid
(CH20H
bo
C -OH
HO-
II
C
11 I
eno-
lize
I lactoniz
H - C-OH
I H
HO- C-H OH O€i
HO-C-H
I I
I
CH20H
CH20H
L-ascorbic acid
(Vitamin C)
Scheme 1: Synthesis of ascorbic acid.
ASCORBIC ACID 65
-
0
II
..
6
COOH COOH C
Q"Dp-
HO
OH
Ho@o-p
OH
,@"20H
OH
UDP-D-Glycuronic D-Glucuronic acid- D-Glucuronic
acid 1-P acid lactone
CH20H CH20H
L-Gulonic acid L-Gulonic acid
lactone
HO-C-H
I I
CH20H CH20H
2-Keto-L-gulonic L-Ascorbic
acid lactone. acid.
5. Metabolism
Ascorbic acid is readily absorbed and metabolised. However,
after oral administration of large quantities, only small
amounts are excreted in the urine while there is a steady
rise in the level of ascorbic acid in the plasma. If the
oral ingestion is continued for a sufficient period, the
plasma concentration rises to a maximum, after which a
rapid urinary excretion of a large part of the ingested
ascorbic acid occurs (22). Ascorbic acid (ASA) and dehydro-
ascorbic acid (DAsA) are metabolized by humans, and the
levels of AsA in blood were maximum at the 4th hr after
AsA administration but at 2nd hr after DAsA administration.
The amount of AsA and DAsA excreted in urine in 6 hr was
respectively. 60 and 70% of the amount excreted in 24 hr
after administration, About 30 and 40% of administered
dose were excreted by men and women respectively in 24 hr.
Of the vitamin excreted after administration of either
AsA or DAsA, about 90 and 10% were in the form of AsA and
DAsA, respectively (23).
The amino acids phenylalanine and tyrosine are not meta-
bolized completely in vitamin C-deficient individuals,
Under these conditions they are metabolized only partly
and are excreted in the urine as homogentisic, p-hydroxy-
phenylpyruvic and p-hydroxyphenyllactic acids. It appears
that vitamin C plays the role of a coenzyme in the meta-
bolism of tyrosine through its deaminated product, because
scorbutic liver slices cannot metabolize this amino acid
in the absence of this vitamin. Vitamin C in adequate
amounts delays the oxidation of epinephrine by the body
(24 1.
6. Daily Requirement!
Ascorbic acid is needed in daily quantities of about 70 mg
to sustain full stamina, and is an essential nutrient for
human beings. In the case of insufficiency the symptoms
of scurvy appears (21).
7. Mode o f Action
We have as yet no complete understanding o f the mode of
action of ascorbic acid. It is, however, known that this
substance is involved in certain hydroxylation reactions
which are catalysed by mixed function oxygenases in the
reduction o f folic acid to tetrahydrofolic acid as well
as well in the regulation of the redox equilibrium between
Fez+ and Fe3+ and Cu" and C U ~ +(21).
ASCORBIC ACID 61
8. Vitamin Defficiency
9. Methods of Analysis
b u t p r e v i o u s l y o x i d i s e d w i t h i o d i n e and
mercuric a c e t a t e be employed. T h i s g e n e r a l l y
e n a b l e s 93 t o 100 p e r c e n t of v i t a m i n C e x p e r i -
m e n t a l l y added t o be determined. I n t h e method
of d e t e r m i n a t i o n with methlene b l u e , t h e r a t i o
o f methylene b l u e used t o v i t a m i n C c o n t e n t
d e c r e a s e s as t h e l a t t e r v a l u e i n c r e a s e s . T h i s
d e c r e a s e of t h e r a t i o i s small; t o o b t a i n s a t i s -
f a c t o r y r e s u l t s , t h e a l i q u o t t i t r a t e d should
n o t c o n t a i n >0.04 mg o f v i t a m i n C . V i s u a l
d e t e r m i n a t i o n o f t h e end-point w i t h t h e a i d
o f a s t a n d a r d i s a g a i n recommended. The i o d i -
m e t r i c method, with potassium i o d a t e was a l s o
s t u d i e d . The c o n c l u s i o n s drawn a r e : 1) t h a t
t h e indophenol method i s s u f f i c i e n t l y a c c u r a t e ,
i s t h e most simple method and h a s t h e w i d e s t
s p h e r e of a p p l i c a t i o n ; 2) t h a t t h e methylene b l u e
method g i v e s r e s u l t s 3 t o 10 p e r c e n t lower
t h a n t h e indophenol method and 3) t h a t t h e
i o d i m e t r i c method g i v e s r ? s u l t s 20 t o 40 p e r
cmt higher (17).
Simple methods o f d e t e r m i n i n g a s c o r b i c
a c i d , t h i a m i n e and n i c o t i n i c a c i d a r e
applied t o mixtures containing t h e s e
vitamins with various pharmaceutical
p r e p a r a t i o n s . Ascorbic a c i d can b e
determined i o d i m e t r i c a l l y i n t h e p r e s e n c e
o f calcium l a c t a t e , p h y t i n g l u c o s e calcium
g l y c e r o p h o s p h a t e , c a f f e i n e sodium b e n z o a t e ,
n i c o t i n i c a c i d , amidopyrine o r t h i a m i n e .
For m i x t u r e c o n t a i n i n g a s c o r b i c a c i d and
nicotinic acid, the ascorbic acid i s deter-
mined i o d i m e t r i c a l l y and t h e t o t a l a c i d i s
70 IBRAHIM A. AL-MESHAL AND MAHMOUD M. A. HASSAN
10. References